Most Expensive
request_quoteIndulge in the exquisite details and unparalleled quality of the most expensive products and assets that define luxury living.
| name | Price | $ Change | % Change | Market Cap | Volume | Avg. Volume | arrow_downwardPE Ratio | Technicals | Dividend Y | ROI 1Y | Score language | Last 7 Days | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ACRSAclaris Therapeutics | $1.25 | -$0.00 | arrow_drop_down0.39% | $132.10M | 305.23K | 1.25 | - | Neutralremove | - | 9.13% | |||||
OZBelpointe PREP, LLC | $64.48 | $0.50 | arrow_drop_up0.77% | $242.44M | 372.00 | 64.98 | - | Neutralremove | - | 7.47% | |||||
AKROAkero Therapeutics | $46.16 | -$2.76 | arrow_drop_down5.63% | $3.18B | 1.22M | 46.80 | - | Neutralremove | - | 125.18% | |||||
ALTGAlta Equipment Group | $4.77 | -$0.15 | arrow_drop_down3.13% | $179.89M | 97.91K | 4.80 | - | Neutralremove | 4.16% | -47.19% | |||||
NEWPNew Pacific Metals | $1.35 | $0.10 | arrow_drop_up8.40% | $194.11M | 347.27K | 1.33 | - | Neutralremove | - | -37.55% | |||||
FDMT4D Molecular Therapeutics | $3.43 | -$0.17 | arrow_drop_down4.86% | $148.23M | 250.33K | 3.45 | - | Neutralremove | - | -86.86% | |||||
FRLA FRLAFortune Rise Acquisition | $11.64 | $11.64 | 0.00% | $36.81M | 13.00 | 11.39 | - | Neutralremove | - | 3.68% | |||||
CYBNCybin | $7.43 | $0.19 | arrow_drop_up2.61% | $137.93M | 181.86K | 7.26 | - | Neutralremove | - | -45.61% | |||||
OCGNOcugen | $0.91 | $0.01 | arrow_drop_up1.24% | $207.13M | 8.89M | 0.95 | - | Neutralremove | - | -46.91% | |||||
IMMXImmix Biopharma, Inc. Common Stock | $1.99 | -$0.40 | arrow_drop_down16.80% | $58.26M | 1.07M | 2.01 | - | Sellkeyboard_arrow_down | - | -7.20% | |||||
INSGInseego | $8.14 | -$0.03 | arrow_drop_down0.36% | $116.00M | 60.19K | 8.18 | - | Neutralremove | - | 20.83% | |||||
ALECAlector | $1.23 | -$0.07 | arrow_drop_down5.34% | $110.49M | 844.14K | 1.25 | - | Neutralremove | - | -77.29% | |||||
ABSIAbsci Corporation | $2.66 | $0.00 | arrow_drop_up0.18% | $377.57M | 1.51M | 2.63 | - | Neutralremove | - | -42.19% | |||||
IKT IKTInhibikase Therapeutics | $1.79 | -$0.04 | arrow_drop_down2.17% | $150.91M | 105.58K | 1.81 | - | Neutralremove | - | -5.02% | |||||
BOOMDMC Global | $6.73 | $0.13 | arrow_drop_up1.96% | $140.56M | 50.93K | 6.65 | - | Neutralremove | - | -49.05% | |||||
INMBInmune Bio | $7.44 | -$0.10 | arrow_drop_down1.33% | $169.20M | 177.44K | 7.50 | - | Neutralremove | - | -30.42% | |||||
PLXProtalix BioTherapeutics | $1.62 | -$0.02 | arrow_drop_down1.21% | $132.94M | 673.90K | 1.63 | - | Neutralremove | - | 25.96% | |||||
 APLDApplied Science Products | $7.34 | -$0.06 | arrow_drop_down0.80% | $1.25B | 22.09M | 7.28 | - | Neutralremove | - | 73.13% | |||||
LCWLearn CW Investment Corporation | $12.69 | $1.82 | arrow_drop_up16.74% | $164.01M | 59.10K | 41.52K | - | Neutralremove | - | 15.36% | |||||
ZNTLZentalis Pharmaceuticals | $1.20 | -$0.03 | arrow_drop_down2.82% | $90.65M | 536.86K | 1.20 | - | Neutralremove | - | -89.94% |
Showing 4581-4600 of 4978
Results per page:
About Most Expensive
Discover the world of the most expensive stocks, where share prices reach extraordinary heights. These stocks command premium valuations, reflecting investor confidence and perceived value in the companies.
Investors seeking prestigious opportunities may find these high-priced stocks alluring, as they often represent established and successful companies with strong market positions.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools